| INTRODUCTION
Intracranial pressure (ICP) refers to the pressure exerted by the intracranial contents against an inelastic cranial vault and is a common consideration in patients with increased intracranial volume secondary to brain trauma, organic brain disease, or after intracranial surgery. Continuous measurement of prolonged intracranial hypertension (ICH) generally is recommended as standard of care in human medicine, particularly in cases of severe head trauma. [1] [2] [3] Monitoring ICP may provide timely information needed to guide early therapeutic intervention, assess response to treatment strategies, decrease indiscriminant treatments, and provide data relevant to prognosis. 1, 3, 4 Abbreviations: CPP, cerebral perfusion pressure; CSF, cerebrospinal fluid; CVP, central venous pressure; ETCO 2 , end-tidal partial pressure of carbon dioxide; HR, heart rate; ICH, intracranial hypertension; ICP, intracranial pressure; LS, least square; MAP, mean arterial pressure; PaCO 2 , arterial carbon dioxide partial pressure; PaO 2 , arterial oxygen partial pressure Cerebral blood flow is critical for normal brain function and is a function of cerebral perfusion pressure (CPP), mean arterial pressure (MAP), and cerebral vascular tone or resistance. Although defining ICP is integral to monitoring CPP (CPP = MAP-ICP), measurement in veterinary practice has been limited because of expense, technical skills required for monitor placement, and compatibility of available monitoring systems with noncompliant animals. Intraventricular ICP devices, fluid-coupled to an external transducer, are considered the "gold standard" for measuring ICP in people, 5 and similar approaches have been reported from a study using experimental dogs. [6] [7] [8] [9] [10] [11] [12] [13] However, marked variation in skull landmarks, variation in ventricular size and location, and the impracticalities of cerebellomedullary cistern placement together with the requirement to maintain the external transducer at head level limit the feasibility of ventricular placement in most clinical situations.
Nonfluid coupled ICP transducers using either catheter tip miniature strain gauges or fiber-optic-linked catheter tip diaphragm technology have distinct advantages over external transducers because these devices do not require "leveling" with the head, although they cannot be recalibrated to zero once they are inserted. Intracranial fiber-optic or solid state capacitance systems have been shown to provide accurate determination of ICP in both cats 14, 15 and dogs, 10, [16] [17] [18] [19] [20] [21] [22] but substantial limitations of this system include the necessity of anchoring the device to the skull by means of a subarachnoid bolt and the inherent fragility of the fiber optics.
Intracranial strain-gauge pressure-sensing devices consisting of a miniaturized silicon transducer enclosed in a titanium case and implanted in the tip of a flexible nylon-covered cable have been described for measurement of ICP in both awake and anesthetized horses under a variety of conditions. [23] [24] [25] [26] [27] [28] [29] Their flexibility, low profile design and ease of use mean they are more easily operated, less prone to breakage and better tolerated in the conscious animal. Data supporting optimal placement of strain-gauge ICP monitoring devices in dogs, in relation to consistency of readings and adverse effects, are not available.
The purposes of our study were to: (1) examine the feasibility of using a transducer-tip intracranial ICP monitor in dogs; (2) determine the variation in ICP measurements obtained from various anatomical locations (subdural versus intraparenchymal; rostral versus caudal) within the cranial vault; (3) evaluate the effects of general anesthesia, recovery, and behavior on ICP measurements in normal dogs; and (4) evaluate histologically the acute effects of subdural versus intraparenchymal catheter placement on intracranial tissues.
| MATERIALS AND METHODS
This was a prospective investigational study conducted at the University of California, Davis, School of Veterinary Medicine. 
| Animals

| Surgical procedure
After anesthetic induction, an 18-gauge 2. 
| ICP manipulations
| Statistical analysis
All data analyses were conducted using R (version 3. Likelihood ratio tests were used to assess the importance of fixed effects. Pairwise comparisons of fixed effect levels were tested using Tukey's adjustment. Statistical significance was considered for P values <.05. 
| RESULTS
| Effect of transducer location
Intracranial pressure measurements did not differ significantly across transducer sites (rostral, caudal, intraparenchymal, and subdural) measured at baseline time points before or after physiological manipulations (P = .19; Figure 2 ). Subsequent analysis of physiological maneuvers was performed on pooled data from all 4 transducer sites.
Mean ICP and CPPs at baseline and maximal manipulation state are summarized in Table 1 .
| Effect of physiological maneuvers
Significant increases in ICP were seen with both increasing jugular occlusion pressure (P < .001) and increasing ETCO 2 (P < .001), and the effect was true for each transducer placement. Pairwise comparisons showed significant differences in ICP with jugular occlusion pressure differences across 20, 40, and 80 mm Hg (P < .05 for all). The magnitude of effect on ICP was decreased at higher occlusion pressures. (Figure 3 , Table 2 ). Significant differences in ICP with increasing ETCO 2 were seen across 40, 50, and 70 mm Hg (P < .05 for all). The magnitude of effect on ICP was decreased at higher ETCO 2 ( Figure 4 , Table 2 ).
| ICP recording in conscious dogs
Post-anesthesia ICP results were found to be significantly different based on both body and head position across time (P < .001; Figure 5 ). Pairwise comparisons showed significant differences in ICP among standing/head elevated, standing/head down, sternal/head elevated, and sternal/head down (P < .05 for all; Table 3 ). Mean values for ICP increased by >100% comparing head elevation to head down positions ( Figure 5 ). Other activities that were noted to 
| Pathology
Grossly, after removal of the dura, the entire surface of the brain 
| DISCUSSION
The Codman MicroSensor has been shown to provide reliable and accurate ICP measurements in human patients compared to a variety of ICP monitoring techniques. [33] [34] [35] [36] [37] The results of our study support the use of the Codman MicroSensor in dogs as a simple method for Likelihood ratio test P value from the linear mixed models showed overall significant effects of both manipulations. a ICP means that have no superscript in common were significantly different from each other (Tukey's honest significance difference test, P < .05). Although clinically apparent neurological deficits were not documented, pathology associated with intraparenchymal placement was predictably more apparent (Figure 6 ), supporting the use of subdural placement. Additionally, the Codman MicroSensor has been shown to be safe, have acceptable function, and produce minimal imaging artifact during MRI as long as manufacturer's imaging guidelines are strictly followed. [38] [39] [40] Choice of monitoring locations for our study was made considering assessment of potential clinical sequelae, including ease of placement, minimization of adverse effects, and reliability of readings.
Noninvasive methods for ICP measurement would have been ideal, but these have not been shown to be sufficiently reliable for routine clinical use. 41, 42 Intraparenchymal transducers are the mainstay for monitoring ICP in humans 5, 43, 44 and provided consistent readings in our study. Subdural transducer placement provided a less invasive option, but less data exist regarding the relative value and accuracy of subdural ICP monitoring devices, and subdural readings may be less accurate than intraparenchymal readings. However, our study found no difference between subdural and intraparenchymal transducer readings, consistent with a previous study in dogs using a bolt-based solid-state transducer 45 and subdural ICP device studies across several species. 25, 36, 37, [45] [46] [47] [48] [49] [50] [51] The effects of head and body position in our study were notable in their magnitude and are relevant to ICP management in the clinical
setting. An increase in ICP associated with head down positioning was seen in all dogs as predicted by ICH physiology, although head position was reported to have no effect on ICP in anesthetized dogs in a previous study. 17 The increase in mean ICP (approximately +7.6 mm Hg/+100%) with head down positioning in sternally recumbent conscious dogs in our study is more consistent with a previous report of similar maneuvers in conscious dogs in lateral recumbency. 10 The maximal recorded increase in mean ICP (approximately +16.5 mm Hg/+180%) occurred after head down positioning in standing dogs ( Figure 5 , Table 3 ) and likely reflects the higher potential for attaining a head position below the level of the heart compared to sternally positioned dogs. Optimal head elevation has been well documented to result in decreased ICP in human traumatic brain injury patients, 52 although effect on clinical outcome is less defined. 53 Large ICP variations with head position in our study in normal dogs similarly highlight 34 Fewer data are available for subdurally placed sensors, however complications in our study and in humans with a subdural Codman MicroSensor also were uncommon. 37 Limitations of our study include lack of measurement of ICP using an intraventricular "gold standard," no assessment of device "drift" anesthetized normal dogs have been reported previously using gold standard direct ventricular CSF measurements, 6 and other intracranial locations (intraparenchymal, subarachnoid, 9, 12, 17, 21 and at the cisterna magna 7, 8 ). Non-anesthetized dogs in sternal recumbency in our study also had mean ICP results in a range (7-15 mm Hg) consistent with previous reports in conscious dogs, suggesting a minimal effect of the anesthesia protocol in these animals. 9, 10 Drift in micro-strain-gauge devices, and specifically in the Codman MicroSensor, has been shown to be small in laboratory studies and in clinical studies in humans, even over several days, [34] [35] [36] and any effects on device location comparisons over 24 hours in our study were likely to be small. No differences were seen in ICP results in our study related to transducer placement within the cranial vault, but it is not possible to extrapolate these findings in normal dogs to a pathological setting. Craniospinal and suprainfratentorial pressure gradients with intracranial lesions generally are accepted to exist, but debate still exists in human medicine regarding the presence of interhemispheric gradients, particularly with focal lesions. [58] [59] [60] After experimental epidural lesions in dogs, 45 no differences were seen in ICP using ipsilateral or contralateral measurements recorded from ventricular, intraparenchymal, or subdural transducer locations. Anecdotally, increased ICP results in the 1 dog ( Figure 5 ) with an intracranial meningioma also were found to be similar for all catheter locations.
Current recommendations in human medicine are to place devices ipsilateral to mass lesions when clinically appropriate. 61 Further study in dogs will be required to define optimal placement relative to specific lesions.
Based on the pathological findings in these dogs, the Codman MicroSensor ICP devices stayed secure throughout the course of the study and appeared to be tolerated well by the animals. 
